Power Law in COVID-19 Cases in China
Behzod B. Ahundjanov, View ORCID ProfileSherzod B. Akhundjanov, Botir B. Okhunjanov
doi: https://doi.org/10.1101/2020.07.25.20161984
Behzod B. Ahundjanov
†Department of Economics, University of Illionois, Chicago, Illionois
Sherzod B. Akhundjanov
Botir B. Okhunjanov
§School of Economic Sciences and Department of Mathematics and Statistics, Washington State University, Pullman, Washington

Article usage
Posted October 22, 2021.
Power Law in COVID-19 Cases in China
Behzod B. Ahundjanov, Sherzod B. Akhundjanov, Botir B. Okhunjanov
medRxiv 2020.07.25.20161984; doi: https://doi.org/10.1101/2020.07.25.20161984
Subject Area
Subject Areas
- Addiction Medicine (227)
- Allergy and Immunology (502)
- Anesthesia (110)
- Cardiovascular Medicine (1234)
- Dermatology (147)
- Emergency Medicine (282)
- Epidemiology (10015)
- Gastroenterology (499)
- Genetic and Genomic Medicine (2449)
- Geriatric Medicine (236)
- Health Economics (479)
- Health Informatics (1638)
- Health Policy (751)
- Hematology (248)
- HIV/AIDS (532)
- Medical Education (252)
- Medical Ethics (74)
- Nephrology (268)
- Neurology (2278)
- Nursing (139)
- Nutrition (350)
- Oncology (1245)
- Ophthalmology (375)
- Orthopedics (133)
- Otolaryngology (226)
- Pain Medicine (155)
- Palliative Medicine (50)
- Pathology (324)
- Pediatrics (729)
- Primary Care Research (282)
- Public and Global Health (4829)
- Radiology and Imaging (834)
- Respiratory Medicine (651)
- Rheumatology (283)
- Sports Medicine (226)
- Surgery (267)
- Toxicology (44)
- Transplantation (125)
- Urology (99)